Overview
Jing-bo Xia practices in Guangzhou, China. Xia is rated as an Advanced expert by MediFind in the treatment of Rhabdomyosarcoma. Their top areas of expertise are Rhabdomyosarcoma, Cerebral Hypoxia, Doxorubicin-Induced Cardiomyopathy, and Cardiomyopathy Due to Anthracyclines.
Their clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Rhabdomyosarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RhabdomyosarcomaXia isAdvanced. Learn about Rhabdomyosarcoma.
- Experienced
- Cardiomyopathy Due to Anthracyclines
- Cerebral HypoxiaXia isExperienced. Learn about Cerebral Hypoxia.
- Doxorubicin-Induced Cardiomyopathy